Hwee Teoh

Terrence Donnelly Laboratories|Division of Respirology and Department of Critical Care|University of Toronto

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers148 papers

Sort

By YearBy Citation

The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

Biswajit Chowdhury, Albert Z Luu, Vincent Z Luu, M Golam Kabir,Yi Pan,Hwee Teoh,Adrian Quan, Sandra Sabongui,Mohammed Al-Omran,Deepak L Bhatt,C David Mazer,Kim A Connelly

Biochemical and Biophysical Research Communications, no. 1 (2020): 50-56

WOSBibtex

Vascular Risk Reduction in Obesity through Reduced Granulocyte Burden and Improved Angiogenic Monocyte Content following Bariatric Surgery

David A Hess, Justin Z Trac, Stephen A Glazer, Daniella C Terenzi,Adrian Quan,Hwee Teoh,Mohammed Al-Omran,Deepak L Bhatt,C David Mazer,Ori D Rotstein,Subodh Verma

Cell Reports Medicine, no. 2 (2020): 100018

WOSBibtex

Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study

Vincent Chan,C David Mazer, Faeez Mohamad Ali,Adrian Quan,Marc Ruel, Benoit E de Varennes,Alexander J Gregory,Denis Bouchard,Richard P Whitlock,Michael W A Chu, Aleksander Dokollari,Thierry Mesana

Circulation, no. 14 (2020): 1342-1350

WOSBibtex

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Vinay Garg,Subodh Verma,Kim A Connelly,Andrew T Yan, Aditya Sikand,Ankit Garg,Paul Dorian, Fei Zuo,Lawrence A Leiter,Bernard Zinman,Peter Jüni,Atul Verma

Metabolism open, (2020): 100039

WOSBibtex

Disruption of endothelial cell intraflagellar transport protein 88 exacerbates doxorubicin-induced cardiotoxicity

Vincent Z Luu, Albert Z Luu, Biswajit Chowdhury, Omar Elbardisy,Yi Pan,Mohammed Al-Omran,Adrian Quan,Hwee Teoh,David A Hess,Subodh Verma

Life sciences, (2020): 118216

WOSBibtex

Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial

Karan Bami, Sumeet Gandhi,Howard Leong-Poi,Andrew T. Yan, Edwin Ho, Mohammed Zahrani, Vinay Garg, Fei Zuo,Hwee Teoh,Adrian Quan,Lawrence A. Leiter,Richard E. Gilbert

Journal of the American Society of Echocardiography, no. 5 (2020): 644-646

Bibtex

The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial

Erika Opingari,Subodh Verma,Kim A Connelly, Cyril David Mazer,Hwee Teoh,Adrian Quan, Fei Zuo,Yi Pan,Deepak L Bhatt,Bernard Zinman,Lawrence A Leiter,Andrew T Yan

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant..., (2020)

WOSBibtex

Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes

Daniella C Terenzi,Mohammed Al-Omran,Adrian Quan,Hwee Teoh,Subodh Verma,David A Hess

JACC: Basic to Translational Science, no. 1 (2019): 98-112

WOSBibtex

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Subodh Verma,C. David Mazer,Andrew T. Yan, Tamique Mason, Vinay Garg,Hwee Teoh, Fei Zuo,Adrian Quan,Michael E. Farkouh,David H. Fitchett,Shaun G. Goodman,Ronald M. Goldenberg

(2019)

Bibtex

P317A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

D C Terenzi,S Verma, J Z Trac,A Quan, T Mason,M Al-Omran, N Dhingra,L A Leiter,B Zinman,A T Yan,K A Connelly,H Teoh

European Heart Journal, (2019)

Bibtex

P1500Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial

K Bami, S Gandhi,H Leong-Poi,A Yan, E Ho, M Zahrani, V Garg,H Teoh,A Quan, D Mazer,S Verma, G Ong

European Heart Journal, (2019)

Bibtex

P5602Comparison of innominate vs axillary artery cannulation for cerebral protection on neurocognitive outcomes in aortic surgery: a pre-specified analysis of the ACE CardioLink-3 randomised trial

V Garg,S Verma,M D Peterson, M W A Chu,A Quan, F Zuo,H Teoh,C D Mazer, E E Smith

European Heart Journal, (2019)

Bibtex

56The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension

B Chowdhury, V Z Luu, A Z Luu, M G Kabir,Y Pan,H Teoh,A Quan,C D Mazer,S Verma

European Heart Journal, (2019)

Bibtex

THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES MORTALITY IN EXPERIMENTAL PULMONARY HYPERTENSION

B. Chowdhury, V. Luu, A. Luu, M. Kabir,Y. Pan,H. Teoh,A. Quan, K. Connelly,C. Mazer,S. Verma

Canadian Journal of Cardiology, no. 10 (2019): S32-S33

Bibtex

A NOVEL ROLE OF SGLT2 INHIBITORS TO INCREASE CIRCULATING PROANGIOGENIC PROGENITOR CELLS IN PATIENTS WITH TYPE 2 DIABETES AND ESTABLISHED CARDIOVASCULAR DISEASE: A SUB-STUDY OF THE EMPA-HEART CARDIOLINK-6 TRIAL

D. Terenzi,S. Verma, J. Trac,A. Quan, T. Mason,M. Al-Omran, N. Dhingra,L. Leiter,B. Zinman,A. Yan,K. Connelly,H. Teoh

Canadian Journal of Cardiology, no. 10 (2019)

Bibtex

LOSS OF ENDOTHELIAL CELL-SPECIFIC INTRAFLAGELLAR TRANSPORT PROTEIN 88 ENHANCES DOXORUBICIN-INDUCED CARDIOTOXICITY-RELATED PHENOTYPES

S. Verma, V. Luu, B. Chowdhury, A. Luu,Y. Pan,A. Quan,H. Teoh, D. Hess

Canadian Journal of Cardiology, no. 10 (2019): S6-S7

Bibtex

EFFECTS OF EMPAGLIFLOZIN ON DIASTOLIC FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

K. Bami, S. Gandhi,H. Leong-Poi,A. Yan, E. Ho, M. Zahrani, F. Zuo, V. Garg,H. Teoh,A. Quan,L. Leiter,B. Zinman

Canadian Journal of Cardiology, no. 10 (2019)

Bibtex

LOSS OF ENDOTHELIAL CELL-SPECIFIC AUTOPHAGY-RELATED PROTEIN 7 EXACERBATES DOXORUBICIN-INDUCED CARDIOTOXICITY

A. Luu, B. Chowdhury, V. Luu,Y. Pan,A. Quan,H. Teoh, D. Hess,S. Verma

Canadian Journal of Cardiology, no. 10 (2019)

Bibtex

Empagliflozin restores the integrity of the endothelial glycocalyx in vitro

Scott Cooper,Hwee Teoh, Marc Antoine Campeau,Subodh Verma,Richard L Leask

Molecular and Cellular Biochemistry, no. 1 (2019): 121-130

WOSBibtex

SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus

David A. Hess, Daniella C. Terenzi, Justin Z. Trac,Adrian Quan, Tamique Mason,Mohammed Al-Omran,Deepak L. Bhatt, Natasha Dhingra,Ori D. Rotstein,Lawrence A. Leiter,Bernard Zinman, Sandra Sabongui

Cell Metabolism, no. 4 (2019): 609-613

Bibtex

View All

Base Info Papers Patents Projects